医学
皮肤病科
脱发
富血小板血浆
疤痕性秃发
强力霉素
非那雄胺
头皮
内科学
血小板
抗生素
前列腺
癌症
微生物学
生物
作者
Elizabeth G. Klein,Maria Karim,Randie H. Kim,Kristen Lo Sicco,Jerry Shapiro
出处
期刊:Journal of Drugs in Dermatology
[SanovaWorks]
日期:2022-05-01
卷期号:21 (6): 671-673
被引量:5
摘要
Lichen planopilaris (LPP) is a cicatricial alopecia that presents with patchy or diffuse hair loss at the vertex or parietal scalp. The literature has limited evidence on treatments for this challenging disease, with most reports involving small groups of patients with varied or suboptimal clinical responses. Amongst individuals who do respond to therapy and eventually achieve disease remission, hair regrowth within scarred alopecic patches is rare.1 Herein, we report a patient with biopsy confirmed LPP who demonstrated remarkable hair regrowth at a previously scarred alopecic patch after initiating low-dose naltrexone (LDN) and platelet-rich plasma (PRP), despite minimal response to 4 months of prior therapy with intralesional corticosteroids, topical clobetasol, topical minoxidil, finasteride, doxycycline, and ketoconazole shampoo. This case highlights the importance of remaining flexible and diligent in therapeutic approaches to LPP and the need for more robust literature on prognosis and treatment options for LPP patients. J Drugs Dermatol. 2022;21(6):671-673. doi:10.36849/JDD.6810.
科研通智能强力驱动
Strongly Powered by AbleSci AI